Skip to main content
Sign in
Sign up
Sign in
Sign up
About
Issues
Editorial Info
Editorial Board
Permissions
Editorial Board Policies
Contributors
Awards and Recognition
Author Guidelines
Poster Presenters Help
Submit a Manuscript
Peer Reviewer Guidelines
Contact
Feedback and Support
Advertising
AAPP
About Psychiatric Pharmacists
About AAPP
AAPP Annual Meeting
Online ACPE Courses
Join AAPP
About
Issues
Editorial Info
Editorial Board
Permissions
Editorial Board Policies
Contributors
Awards and Recognition
Author Guidelines
Poster Presenters Help
Submit a Manuscript
Peer Reviewer Guidelines
Contact
Feedback and Support
Advertising
AAPP
About Psychiatric Pharmacists
About AAPP
AAPP Annual Meeting
Online ACPE Courses
Join AAPP
Issue Info
Issues
Volume 5: Issue 6
Publication Date:
01 Nov 2015
Online ISSN:
2168-9709
Issues
Volume 5: Issue 6
Publication Date:
01 Nov 2015
Online ISSN:
2168-9709
Select Issue
CLINICAL PEARL
Off-label use of gabapentin for management of alcohol use disorders
Taylor A. Nichols
PharmD
DOI:
10.9740/mhc.2015.11.248
Abstract
Download PDF
LITERATURE REVIEWS
Triiodothyronine (T3) supplementation in major depressive disorder
Anna K. Morin
PharmD
DOI:
10.9740/mhc.2015.11.253
Abstract
Download PDF
Selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors for menopausal vasomotor symptoms
Kathryn M. Holt
PharmD
and
Amy N. Thompson
PharmD, BCACP, CDE
DOI:
10.9740/mhc.2015.11.260
Abstract
Download PDF
Off-label use of mirtazapine for anxiety
John Begert
PharmD
and
Bridget Bradley
PharmD, BCPP
DOI:
10.9740/mhc.2015.11.265
Abstract
Download PDF
The role of methylphenidate in depression
Meghan Ellinger May
PharmD
and
Amy VandenBerg
PharmD, BCPP
DOI:
10.9740/mhc.2015.11.271
Abstract
Download PDF
CASE REPORT
Off-label use of duloxetine for pediatric neuropathic pain
K. J. Burghardt
PharmD
,
S. T. Thomas
MD
, and
V. Tutag-Lehr
PharmD
DOI:
10.9740/mhc.2015.11.277
Abstract
Download PDF
REVIEW OF DRUGS/PHARMACOTHERAPY
Pharmacologic basis for the use of selective norepinephrine reuptake inhibitors for the treatment of neuropathic pain conditions
Michael Webster
PharmD
DOI:
10.9740/mhc.2015.11.284
Abstract
Download PDF
Evidence and clinical considerations for the use of serotonin and norepinephrine reuptake inhibitors for the treatment of painful neuropathy
Meredith Sigler
PharmD, BCPS
,
Amy VandenBerg
PharmD, BCPP
, and
Amy Thompson
PharmD, BCACP, CDE
DOI:
10.9740/mhc.2015.11.289
Abstract
Download PDF
Get Email Alerts
Get eTOC Alerts
Get Ahead of Print Alerts
Guanfacine for the management of the behavioral manifestations of delirium in older hospitalized adults
Kayla Garvey
PharmD
,
Kobi Griffith
PharmD
,
Emily Carter
MD
,
Wendy Craig
PhD
,
David J. Gagnon
PharmD
,
Richard Riker
MD
, and
Nicolette Centanni
PharmD
Clozapine plasma level toxicity induced by a pharmacokinetic interaction with bupropion: A case report
Kelly N. Gable
PharmD, BCPP
and
Jaron Asher
MD
Impact of psychiatric pharmacist-led ambulatory alcohol withdrawal management
Maxwell Lamb
PharmD, BCPS
,
Michelle Colvard
PharmD, BCPP
,
Jonathan Lister
PharmD, BCPP
, and
Eric Johnson
PharmD, BCPP
Evaluation of burnout among Board-Certified Psychiatric Pharmacists in the United States
Samantha Catanzano
PharmD, BCPP
,
Jennifer N. Gemmellaro
PharmD, BCPP, BCPS
,
Melissa Mooers Gross
BS, PharmD, MHA, BCPP, BCPS, BCGP, BCIDP, CPEL, CPPS
,
Monica Fahmy
PharmD, BCPP, BCPS
,
Gregory H. Payne
MBA, CAE
, and
Kelly C. Lee
PharmD, MAS, BCPP, FCCP
Management of antidepressant-induced bruxism
Hayley Cliatt
PharmD
,
Andrew M. Williams
PharmD, BCPP
, and
Jessa Koch
PharmD, BCPP
About
Issues
Advertising
Permissions
Facebook
X
LinkedIn
eISSN
: 2168-9709
Powered by
PubFactory